• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
ebola
JOIN
Posted on October 11, 2023October 11, 2023

Understanding the Etiologies of Adverse Events Following Immunization via the International Network of Specialist Immunization Services

This editorial was previously published in Vaccine Safety Quarterly. Karina Top, MD, MS Vaccine safety has been my prim...
Read More
Posted on September 28, 2023January 2, 2024

Request for Review: Autoimmune Hepatitis Case Definition

On behalf of the Brighton Collaboration Autoimmune Hepatitis Case Definition Working Group, please find below a manuscript on “A...
Read More
Posted on May 2, 2023September 21, 2023

BC Peer Review Needed: B-R Assessment Manuscript and Case Study

Digital,digital
Read More
Posted on March 12, 2023September 20, 2023

Maternal Immunization Working Group Meeting Report (November 2022)

On 8 and 9 November 2022, the Maternal Immunization Working Group (MIWG) held an in-person and online hybrid meeting. The objectiv...
Read More
Posted on February 17, 2023August 9, 2023

Reactivation of the Brighton Collaboration Digital Innovations in Vaccine Safety (DIVaS) Working Group

Digital,digital
Read More
Posted on December 19, 2022October 23, 2023

CEPI expands partnership with Brighton Collaboration to support safety assessment of vaccine candidates

The Coalition for Epidemic Preparedness Innovations (CEPI) and the Brighton Collaboration, based in Atlanta at The Task Force fo...
Read More
Posted on November 11, 2022August 9, 2023

COVID-19 AESI List 5th Update – October 2022

SPEAC has completed a fifth update to the Priority List of potential Adverse events of special interest relevant to COVID-19 vacci...
Read More
Posted on September 23, 2022August 9, 2023

International Society of Pharmacoepidemiology (ISPE) COVID19-related Award: Robert T. Chen MD MA FISPE

We are proud to announce that Dr. Bob Chen, Scientific Director of the Brighton Collaboration, received a special award for “Co...
Read More
Posted on July 28, 2022June 26, 2023

Director of Research – Brighton Collaboration

To help meet its increasing needs, the Secretariat for the Brighton Collaboration (BC) has recently posted a new staff position:...
Read More
Posted on February 9, 2022August 9, 2023

CEPI Sponsored DSMB Training Course

Coalition for Epidemic Preparedness Innovations (CEPI) through the Safety Platform for Emergency vACcines (SPEAC) project, has f...
Read More
Previous page 1 2 3 4 5 Next page

Recent Posts

  • Fetal VacciniaAugust 10, 2026
  • Acute Intraocular InflammationJuly 1, 2026
  • Acute Multi-Organ DysfunctionJune 2, 2026
  • WHO Resource References Brighton Collaboration StandardsMay 11, 2026
  • Request for Review: Acute Multi-Organ Dysfunction (aMOD) Brighton Case DefinitionFebruary 4, 2026

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy